MUSECHEM: ENHANCING RESEARCH WITH TOP-NOTCH CHEMICALS

The MAPK/ERK signaling pathway is one more critical target for inhibitors. This pathway is included in managing cell survival, distinction, and development. Inhibitors targeting MAPK/ERK are employed in cancer therapies to avoid uncontrolled cell proliferation and tumor development. Similarly, JAK/STAT signaling inhibitors modulate immune feedbacks